cariprazine
SMILES | O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl |
InChIKey | KPWSJANDNDDRMB-QAQDUYKDSA-N |
Chemical properties
Hydrogen bond acceptors | 3 |
Hydrogen bond donors | 1 |
Rotatable bonds | 5 |
Molecular weight (Da) | 426.2 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.24 | 8.24 | 8.24 | Guide to Pharmacology |
D3 | DRD3 | Human | Dopamine | A | pKi | 10.05 | 10.05 | 10.05 | Guide to Pharmacology |
D5 | DRD5 | Human | Dopamine | A | pKi | 5.1 | 5.1 | 5.1 | ChEMBL |
5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 6.96 | 6.96 | 6.96 | ChEMBL |
H1 | HRH1 | Human | Histamine | A | pKi | 7.63 | 7.63 | 7.63 | ChEMBL |
D4 | DRD4 | Human | Dopamine | A | pKi | 6.29 | 6.63 | 6.96 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.47 | 5.57 | 5.68 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.7 | 6.7 | 6.7 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 9.57 | 9.84 | 10.07 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.66 | 7.39 | 7.73 | ChEMBL |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 8.4 | 8.5 | 8.59 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 6.99 | 8.9 | 9.39 | ChEMBL |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.11 | 8.11 | 8.11 | Drug Central |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.03 | 8.03 | 8.03 | Drug Central |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.18 | 8.18 | 8.18 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.03 | 8.03 | 8.03 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.0 | 8.0 | 8.0 | Drug Central |
D4 | DRD4 | Human | Dopamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
D5 | DRD5 | Human | Dopamine | A | pKi | 8.29 | 8.29 | 8.29 | Drug Central |
H1 | HRH1 | Human | Histamine | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
D1 | DRD1 | Human | Dopamine | A | pKi | 8.25 | 8.25 | 8.25 | Drug Central |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
D3 | DRD3 | Rat | Dopamine | A | pIC50 | 8.8 | 8.8 | 8.8 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pEC50 | 8.24 | 8.24 | 8.24 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pEC50 | 6.95 | 8.59 | 9.74 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pIC50 | 8.77 | 8.77 | 8.78 | ChEMBL |
D3 | DRD3 | Rat | Dopamine | A | pIC50 | 8.06 | 8.06 | 8.06 | Drug Central |
D2 | DRD2 | Rat | Dopamine | A | pIC50 | 8.11 | 8.11 | 8.11 | Drug Central |
D2 | DRD2 | Rat | Dopamine | A | pIC50 | 7.8 | 7.8 | 7.8 | ChEMBL |